Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7763]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
The development of PARP inhibitors a new drug to treat prostate cancer
Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital...
The development of PARP inhibitors a new drug to treat prostate cancer ( Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK )
10 Nov 2010
Treatment of neuroendocrine tumours with everolimus
Dr Nicola Fazio - European Institute of Oncology, Milan, Italy
Treatment of neuroendocrine tumours with everolimus ( Dr Nicola Fazio - European Institute of Oncology, Milan, Italy )
10 Nov 2010
The impact of mapping the human genome on cancer therapies
Dr Kevin Davies - Bio-IT World, Massachusetts, USA
The impact of mapping the human genome on cancer therapies ( Dr Kevin Davies - Bio-IT World, Massachusetts, USA )
10 Nov 2010
GOG-218: Bevacizumab plus standard chemo for ovarian cancer
Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA
GOG-218: Bevacizumab plus standard chemo for ovarian cancer ( Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA )
10 Nov 2010
Pain management and the treatment of cancer patients with low blood counts
Prof Dorothy Keefe - The University of Adelaide, Australia
Pain management and the treatment of cancer patients with low blood counts ( Prof Dorothy Keefe - The University of Adelaide, Australia )
10 Nov 2010
Bevacizumab as part of standard first line treatment of ovarian cancer
Prof Jonathan Ledermann - University College London, UK
Bevacizumab as part of standard first line treatment of ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
10 Nov 2010
The treatment of advanced pancreatic neuroendocrine tumours (pNET)
Prof Kjell Öberg - University Hospital, Uppsala, Sweden
The treatment of advanced pancreatic neuroendocrine tumours (pNET) ( Prof Kjell Öberg - University Hospital, Uppsala, Sweden )
4 Nov 2010
Clinical trial design, biomarkers development and the treatment of neuropathic...
Dr Marina Garassino - Fatebenefratelli Hospital, Milan, Italy
Clinical trial design, biomarkers development and the treatment of neuropathic pain ( Dr Marina Garassino - Fatebenefratelli Hospital, Milan, Italy )
4 Nov 2010
Key research from ESMO 2010
Prof Jim Cassidy - University of Glasgow, UK
Key research from ESMO 2010 ( Prof Jim Cassidy - University of Glasgow, UK )
1 Nov 2010
The ICON7 trial
Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK
The ICON7 trial ( Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK )
1 Nov 2010
PARP inhibitors
Prof Ruth Plummer - Newcastle University, UK
PARP inhibitors ( Prof Ruth Plummer - Newcastle University, UK )
1 Nov 2010
ESTRO 2010 - Snapshots from the conference
European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12...
ESTRO 2010 - Snapshots from the conference ( European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010 )
25 Oct 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation